ClinicalTrials.Veeva

Menu

An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty

Mount Sinai Hospital, Canada logo

Mount Sinai Hospital, Canada

Status

Unknown

Conditions

Leg Length Discrepancy
Dislocation
Hip Osteoarthritis

Treatments

Device: Intellijoint HIP
Device: Outrigger

Study type

Interventional

Funder types

Other

Identifiers

NCT02095093
Intellijoint HIP

Details and patient eligibility

About

Leg length discrepancies following total hip arthroplasty have been associated with nerve palsies, gait abnormalities, and lower back pain. Leg length discrepancies are related to poorer functional outcomes and patient dissatisfaction. Failure to restore femoral offset following total hip arthroplasty has been linked to decreased range of motion and abductor muscle strength, impingement, limping, higher dislocation rates, increased polyethylene wear, and loosening of implants. Computer navigation has shown to improve the accuracy of leg length and hip offset during total hip arthroplasty. The investigators research objective is to prove the accuracy of the Intellijoint HIP™ system for determining leg length and hip offset. The investigators hypothesis was that Intellijoint HIP™, an imageless intraoperative intelligent instrument, could improve the accuracy of leg length and hip offset during primary total hip arthroplasty. The investigators plan to study this hypothesis in humans by comparing the leg length and hip offset discrepancies produced with Intellijoint HIP™ to the standard at the investigators institution, which is a pin and outrigger system.

Enrollment

128 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Any patient who is undergoing a primary total hip arthroplasty at Mount Sinai Hospital.

Exclusion criteria

  • Pre-operative flexion contracture >30°, infection, or inability to achieve rigid fixation of instruments intra-operatively.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

128 participants in 2 patient groups

Intellijoint HIP
Experimental group
Description:
Patient's will have their leg length and hip offset determined intraoperatively using Intellijoint HIP.
Treatment:
Device: Intellijoint HIP
Outrigger
Active Comparator group
Description:
Control patients will have their leg length and hip offset determined intra-operatively using the standard at Mount Sinai Hospital, which is a pin and outrigger system.
Treatment:
Device: Outrigger

Trial contacts and locations

1

Loading...

Central trial contact

Paul Kuzyk, MD; Jesse I Wolfstadt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems